Identification of potential tumour-associated carbonic anhydrase isozyme IX inhibitors: atom-based 3D-QSAR modelling, pharmacophore-based virtual screening and molecular docking studies

References

• Alterio, V., Di Fiore, A., D’Ambrosio, K., Supuran, C. T., & De Simone, G. (2012). Multiple binding modes of inhibitors to carbonic anhydrases: How to design specific drugs targeting 15 different isoforms? Chemical Reviews, 112(8), 4421–4468. doi:10.1021/cr200176r
   PubMed Web of Science ®Google Scholar
• Bozdag, M. (2014). Combining the tail and the ring approaches for obtaining potent and isoform-selective carbonic anhydrase inhibitors: Solution and X-ray crystallographic studies. Bioorganic & Medicinal Chemistry, 22(1), 334–340. doi:10.1016/j.bmc.2013.11.016
   PubMed Web of Science ®Google Scholar
• Dixon, S. L., Smondyrev, A. M., Knoll, E. H., Rao, S. N., Shaw, D. E., & Friesner, R. A. (2006). PHASE: A new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results. Journal of Computer-Aided Molecular Design, 20(10–11), 647–671. doi:10.1007/s10822-006-9087-6
   PubMed Web of Science ®Google Scholar
• Dubois, L., Peeters, S., Lieuwes, N. G., Geusens, N., Thiry, A., Wigfield, S., … Lambin, P. (2011). Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation. Radiotherapy and Oncology, 99(3), 424–431. doi:10.1016/j.radonc.2011.05.045
   PubMed Web of Science ®Google Scholar
• Finger, E. C., & Giaccia, A. J. (2010). Hypoxia, inflammation, and the tumor microenvironment in metastatic disease. Cancer and Metastasis Reviews, 29(2), 285–293. doi:10.1007/s10555-010-9224-5
   PubMed Web of Science ®Google Scholar
• Gallori, E. (2003). ‘Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides’. Bioorganic & Medicinal Chemistry Letters, 13(6), 1005–1009. doi:10.1016/S0960-894X(03)00091-X
   PubMed Web of Science ®Google Scholar
• Grabmaier, K., Vissers, J. L. M., De Weijert, M. C. A., Oosterwijk-Wakka, J. C., Van Bokhoven, A., Brakenhoff, R. H., … Oosterwijk, E. (2000). Molecular cloning and immunogenicity of renal cell carcinoma-associated antigen G250. International Journal of Cancer, 85(6), 865–870. doi:10.1002/(SICI)1097-0215(20000315)85:6 < 865::AID-IJC21 > 3.0.CO;2-Q
   PubMed Web of Science ®Google Scholar
• Ibrahim, H. S., Allam, H. A., Mahmoud, W. R., Bonardi, A., Nocentini, A., Gratteri, P., … Supuran, C. T. (2018). Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: Selective inhibitors for the tumor-associated hCA IX isoform. European Journal of Medicinal Chemistry, 152, 1–9. doi:10.1016/j.ejmech.2018.04.016
   PubMed Web of Science ®Google Scholar
• Irwin, J. J., Sterling, T., Mysinger, M. M., Bolstad, E. S., & Coleman, R. G. (2012). ZINC: A free tool to discover chemistry for biology. Journal of Chemical Information and Modeling, 52(7), 1757–1768. doi:10.1021/ci3001277
   PubMed Web of Science ®Google Scholar
• Kirchmair, J., Markt, P., Distinto, S., Wolber, G., & Langer, T. (2008). Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection—What can we learn from earlier mistakes? Journal of Computer-Aided Molecular Design, 22(3–4), 213–228. doi:10.1007/s10822-007-9163-6
   PubMed Web of Science ®Google Scholar
• Madhavi Sastry, G., Adzhigirey, M., Day, T., Annabhimoju, R., & Sherman, W. (2013). Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. Journal of Computer-Aided Molecular Design, 27(3), 221–234. doi:10.1007/s10822-013-9644-8
   PubMed Web of Science ®Google Scholar
• McDonald, P. C. (2012). Recent developments in targeting carbonic anhydrase IX for cancer therapeutics. Oncotarget, 3(1), 84–97. doi:10.18632/oncotarget.422
   PubMed Web of Science ®Google Scholar
• Mucaj, V., Shay, J. E. S., & Simon, M. C. (2012). Effects of hypoxia and HIFs on cancer metabolism. International Journal of Hematology, 95(5), 464–470. doi:10.1007/s12185-012-1070-5
   PubMed Web of Science ®Google Scholar
• Neri, D., & Supuran, C. T. (2011). Interfering with pH regulation in tumours as a therapeutic strategy. Nature Reviews Drug Discovery, 10(10), 767–777. doi:10.1038/nrd3554
   PubMed Web of Science ®Google Scholar
• Nishimori, I., Minakuchi, T., Vullo, D., Scozzafava, A., Innocenti, A., & Supuran, C. T. (2009). Carbonic Anhydrase Inhibitors. Cloning, characterization, and inhibition studies of a new β-carbonic anhydrase from Mycobacterium tuberculosis. Journal of Medicinal Chemistry, 52(9), 3116–3120. doi:10.1021/jm9003126
   PubMed Web of Science ®Google Scholar
• Nocentini, A., Ferraroni, M., Carta, F., Ceruso, M., Gratteri, P., Lanzi, C., … Supuran, C. T. (2016). Benzenesulfonamides incorporating flexible triazole moieties are highly effective carbonic anhydrase inhibitors: Synthesis and kinetic, crystallographic, computational, and intraocular pressure lowering investigations. Journal of Medicinal Chemistry, 59(23), 10692–10704. doi:10.1021/acs.jmedchem.6b01389
   PubMed Web of Science ®Google Scholar
• Opavský, R., Pastoreková, S., Zelnı́k, V., Gibadulinová, A., Stanbridge, E. J., Závada, J., … Pastorek, J. (1996). HumanMN/CA9Gene, a novel member of the carbonic anhydrase family: Structure and exon to protein domain relationships. Genomics, 33(3), 480–487. doi:10.1006/geno.1996.0223
   PubMed Web of Science ®Google Scholar
• Friesner, R. A. (2006). Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein − ligand complexes. American Chemical Society, 49(21), 6177-6196. doi:10.1021/JM051256O
   Google Scholar
• Scozzafava, A., Menabuoni, L., Mincione, F., Briganti, F., Mincione, G., & Supuran, C. T. (1999). Carbonic anhydrase ionhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: Is the tail more important than the ring? Journal of medicinal chemistry, 42(14), 2641-2650. doi:10.1021/JM9900523
   Google Scholar
• Schrödinger Release 2019-1 (2019). QikProp. New York, NY: Schrödinger, LLC.
   Google Scholar
• Semenza, G. L. (2009). Regulation of cancer cell metabolism by hypoxia-inducible factor. Seminars in Cancer Biology, 19(1), 12. doi:10.1016/j.semcancer.2008.11.009
   PubMed Web of Science ®Google Scholar
• Supuran, C. T. (2008). Carbonic anhydrases: Novel therapeutic applications for inhibitors and activators. Nature Reviews Drug Discovery, 7(2), 168–181. doi:10.1038/nrd2467
   PubMed Web of Science ®Google Scholar
• Supuran, C. T. (2015). Efficient expression and crystallization system of cancer-associated carbonic anhydrase isoform IX. Journal of Medicinal Chemistry, 58(22), 9004–9009. doi:10.1021/acs.jmedchem.5b01343
   PubMed Web of Science ®Google Scholar
• Supuran, C. T. (2016). How many carbonic anhydrase inhibition mechanisms exist? Journal of Enzyme Inhibition and Medicinal Chemistry, 31(3), 345–360. doi:10.3109/14756366.2015.1122001
   PubMed Web of Science ®Google Scholar
• Supuran, C. T., Alterio, V., Di Fiore, A., D’ Ambrosio, K., Carta, F., Monti, S. M., & De Simone, G. (2018). Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: Three for the price of one. Medicinal Research Reviews, 38(6), 1799–1836. doi:10.1002/med.21497
   PubMed Web of Science ®Google Scholar
• Turkmen, H., Durgun, M., Yilmaztekin, S., Emul, M., Innocenti, A., Vullo, D., … Supuran, C. T. (2005). Carbonic anhydrase inhibitors. Novel sulfanilamide/acetazolamide derivatives obtained by the tail approach and their interaction with the cytosolic isozymes I and II, and the tumor-associated isozyme IX. Bioorganic and Medicinal Chemistry Letters, 15(2), 367–372. doi:10.1016/j.bmcl.2004.10.070
   PubMed Web of Science ®Google Scholar
• Vullo, D., Scozzafava, A., Pastorekova, S., Pastorek, J., & Supuran, C. T. (2004). Carbonic anhydrase inhibitors: Inhibition of the tumor-associated isozyme IX with fluorine-containing sulfonamides. The first subnanomolar CA IX inhibitor discovered. Bioorganic and Medicinal Chemistry Letters, 14(9), 2351–2356. doi:10.1016/j.bmcl.2004.01.095
   PubMed Web of Science ®Google Scholar
• Wilson, W. R., & Hay, M. P. (2011). Targeting hypoxia in cancer therapy. Nature Reviews Cancer, 11(6), 393–410. doi:10.1038/nrc3064
   PubMed Web of Science ®Google Scholar
• Wykoff, C. C. (2000). Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Research, 60(24), 7075–7083. doi:10.1158/0008-5472.can-08-2470
   PubMed Web of Science ®Google Scholar